Atlas Trials

An Explorative Study of HRS-2189 Combined With Adebrelimab and BP102 for Metastatic Colorectal Cancer

Clinical trial NCT07061210 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07061210
Sponsor
Fudan University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Cancer Metastatic
Start date
2025-07-01
Primary completion
2026-10-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.